Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of Baricitinib for Frontal Fibrosing Alopecia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontal Fibrosing Alopecia

Drugs mentioned

• Olumiant (baricitinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Frontal Fibrosing Alopecia | Phase 4 | Status: ACTIVE_NOT_RECRUITING